Hexarelin is a synthetic GHRP-6 analog and a potent GH secretagogue with documented cardioprotective effects in preclinical models, mediated in part via CD36.
Hexarelin is a synthetic hexapeptide in the GHRP family — a close analog of GHRP-6 — and one of the more potent growth-hormone secretagogues studied. It activates the ghrelin receptor (GHS-R1a) on pituitary somatotrophs.
A distinctive research thread is its action at the CD36 receptor, through which preclinical studies report cardioprotective effects independent of GH release. It is not FDA-approved.
GHS-R1a and CD36 agonism.
Behind every vial of Hexarelin is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Hexarelin, specifically, is brought into being.
On paper, Hexarelin is C47H58N12O6 — about 887 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Hexarelin's chain is short but unusual — it carries D-amino acids and non-natural residues that help it resist enzymatic breakdown, but demand specialized, costlier building blocks and careful coupling on the synthesizer. Its C-terminus is amidated rather than left as a free acid — a defined modification the synthesis has to deliver, not an afterthought.
The crude mixture — Hexarelin plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Hexarelin proves itself: identity confirmed by mass spectrometry against its ~887 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Hexarelin — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Producing Hexarelin to a genuine purity spec means solid-phase synthesis, preparative HPLC purification, and batch quality control — none of it cheap, and none of it something you can verify by eye.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Hexarelin is a potent synthetic GHRP (a GHRP-6 analog) studied for growth-hormone release and, separately, cardioprotective effects.
Beyond GH release, hexarelin binds the CD36 receptor, through which preclinical studies report cardioprotective activity.
Both are GHRPs, but hexarelin is more potent and less selective; ipamorelin is valued for releasing GH with minimal cortisol or prolactin effect.
No — it is a research compound. This page is a research and educational reference.
Recombinant 191-amino-acid human growth hormone — a folded protein biologic identical in sequence to pituitary GH, not a synthetic research peptide.
ViewThe downstream effector of growth hormone — a 70-amino-acid recombinant protein, structurally a cousin of proinsulin, that carries out most of GH’s growth signal.
ViewA long-acting modified IGF-1 analog with reduced IGFBP binding and prolonged systemic activity.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.